Foreign investors have shifted their strategy in October, investing ₹2,599 crore into Indian IT stocks while selling ₹5,497 crore of healthcare holdings. This movement occurs against a wider backdrop of foreign selling across Indian markets, which has exceeded ₹50,000 crore this month due to global economic pressures like high US bond yields and a strong dollar.
Foreign investors are changing their approach to the Indian stock market this October, rotating capital out of the healthcare sector and into information technology companies. Official data shows that these investors have poured ₹2,599 crore into IT stocks, while selling ₹5,497 crore worth of healthcare shares during the first half of the month. This shift is notable because it reverses a trend from the previous three months, where foreign funds had consistently favored healthcare.
The IT sector has seen a strong rally, with the Nifty IT index rising 10.88 percent in recent months. Investors appear to be attracted by current valuations, as these stocks are trading at approximately 18 times their expected yearly earnings, which is lower than the five-year average of 23 times. While this valuation gap is drawing interest, the sector faces future challenges. Potential pricing pressure driven by artificial intelligence (AI) could impact profit margins for IT firms in the coming fiscal year, a factor that investors should monitor alongside quarterly results.
On the other hand, the healthcare sector is seeing a period of heavy selling. After a three-month stretch that saw ₹15,779 crore in inflows, investor sentiment has turned cautious. A significant contributor to this shift is the regulatory environment. New government price caps on non-scheduled anti-cancer drugs have created concerns about the profitability of hospital chains. Because of these margin pressures, analysts are now suggesting a more defensive approach, with some focusing on diagnostics and pharmacy businesses rather than hospital networks.
These sectoral moves are taking place within a broader environment of foreign selling. With total outflows exceeding ₹50,000 crore in October, foreign funds are dealing with persistent global challenges. Factors such as elevated crude oil prices, a stronger dollar, and high US bond yields have reduced the appeal of emerging markets. These external pressures are driving high volatility, making foreign investors more selective about where they place their capital.
Going forward, the stability of these investment flows will likely depend on global interest rates and the performance of Indian corporate earnings. For shareholders, the key monitorables include how effectively IT firms manage potential pricing changes and whether healthcare providers can maintain their profitability despite new drug pricing regulations.